Compounds as metabotropic glutamate receptor antagonists
US7504404B2 · kind B2 · utility
5Cited by
4References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 2006 |
| Grant date | Mar 17, 2009 |
| Priority date | — |
| Expiry date | Apr 28, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I)wherein A, E G, J, L, M, R1, R2, and R3 are as defined in the specification and claims. The invention also relates to pharmaceutical compositions containing such compounds and methods for preparing the compounds and compositions. The compounds are metabotropic glutamate receptor antagonists and are useful for the treatment of a variety of CNS disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.